- Identifying predictors of response to unresectable hepatocellular carcinoma treatment with checkpoint inhibitors remains a challenge for the future2021 | Publication without faculty affiliation
- Hepatocellular carcinoma2010 | First Faculty of Medicine
- Hepatocellular carcinoma clinical register2010 | First Faculty of Medicine
- Systemic treatment of hepatocellular carcinoma2022 | Third Faculty of Medicine
- New possibility of the hepatocellular carcinoma therapy (HCC) +12009 | Faculty of Medicine in Hradec Králové
- New possibility of the hepatocellular carcinoma therapy (HCC)2009 | First Faculty of Medicine
- Sternal metastasis as the first symptom of the hepatocellular carcinoma2006 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Biological treatment of hepatocellular carcinoma2010 | First Faculty of Medicine
- Place of sorafenib in the treatment of hepatocellular carcinoma2010 | First Faculty of Medicine
- Screening and surveillance for hepatocellular carcinoma2013 | First Faculty of Medicine
- Surgical Treatment of hepatocellular carcinoma2020 | Faculty of Medicine in Pilsen
- Systemic cancer treatment of hepatocellular carcinoma2019 | Faculty of Medicine in Pilsen
- Recommended procedures for the treatment and diagnostics of hepatocellular carcinoma2012 | First Faculty of Medicine
- Is PIVKA-II a Promising Biomarker for Hepatocellular Carcinoma?2020 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Hepatocellular carcinoma - long-term treatable disease2012 | Faculty of Medicine in Pilsen
- Hepatocellular carcinoma invading the right atrium2010 | First Faculty of Medicine
- Therapy of hepatocellular carcinoma in Asia: consensus of Asian summit of oncology 20092010 | First Faculty of Medicine
- Hepatic arterial infusion in hepatocellular carcinoma: a single center experience2015 | Faculty of Medicine in Hradec Králové
- New options in deciding about targeted treatment of hepatocellular carcinoma2015 | First Faculty of Medicine
- Advanced hepatocellular carcinoma and successfully targeted the first-line treatment with atezolizumab and bevacizumab according to IMbrave150 trial2021 | Faculty of Medicine in Pilsen
- Hepatocellular carcinoma from the view of gastroenterologist/hepatologist2020 | First Faculty of Medicine
- Atezolizumab and bevacizumab in the treatment of hepatocellular carcinoma2020 | Faculty of Medicine in Pilsen
- PIVKA-II as a Potential New Biomarker for Hepatocellular Carcinoma - A Pilot Study2018 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Hepatocellular carcinoma - our experience with surveillance, effect and complications of transarterial chemoembolization2013 | First Faculty of Medicine
- Hepatocellular carcinoma – screening, diagnostics, classification and treatement2011 | First Faculty of Medicine
- Complementary role of two - phase multidetector CT - angiography and 18 F - FDG - PET in hybrid PET/CT imaging of the hepatocellular carcinoma2007 | Faculty of Medicine in Pilsen
- Complementary role of two - phase multidetector CT - angiography and 18 F - FDG - PET in hybrid PET/CT imaging of the hepatocellular carcinoma2007 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Current findings regarding pharmacological treatment of advanced hepatocellular carcinoma (HCC)2013 | First Faculty of Medicine
- Hepatocellular carcinomaPublication without faculty affiliation